scorecard

You Searched For "Sanofi" and got 19 results


Sort By:


Business Insider Latest Story Image

Connecting with marketing peers helps CMOs stay on top of trends, says Claudine Patel, CMO of Sanofi Consumer Healthcare

Marketing is dynamic and constantly changing, so networking with a CMO peer group is key to keeping…

Business Insider Latest Story Image
2 mins read

Sanofi board approves demerger of its consumer healthcare business

Drug firm Sanofi India on Wednesday said its board has approved the demerger of its consumer health…

PTI   


Business Insider Latest Story Image
1 min read

Time to bet on dividend income: Top stocks that delivered the highest yield over one year

From the Anil Agarwal-led Vedanta to Hindustan Zinc and Sanofi, here are the companies in the Nifty…

Business Insider Latest Story Image
1 min read

Sanofi, GSK to seek authorisation for COVID-19 vaccine

Late-stage trials found that two doses of the vaccine were about 58% effective in preventing infect…

Business Insider Latest Story Image
1 min read

Translate Bio soars 30% after Sanofi agrees to buy the mRNA company for $3.2 billion

The deal represents a 56% premium to Translate Bio's volume-weighted average price per share over t…

Matthew Fox   


Business Insider Latest Story Image
2 mins read

India's drug controller grants approval to Sanofi and Glaxo Smith Kline to conduct Phase-3 trials of their COVID-19 vaccine

The global, randomised, double-blind Phase-III study will include more than 35,000 volunteers ag…

Business Insider Latest Story Image
2 mins read

These are the fastest-growing biotech companies

These are Insider's biggest healthcare stories for May 18.

Lydia Ramsey Pflanzer   


Business Insider Latest Story Image
1 min read

Sanofi and GlaxoSmithKline say their COVID-19 vaccine triggers a strong immune response, bolstering the late-comer program's potential as a booster shot

The two vaccine-making giants plan to launch a 35,000-person study in the next few weeks, aiming to…

Andrew Dunn   


Business Insider Latest Story Image
7 mins read

There are one of only 17 Indian companies out of 500 that aced the Du Pont test

Du Pont Corporation in America used a method to calculate the return on equity⁠— which shows how pr…

Grace Dean   


Business Insider Latest Story Image
2 mins read

French drugmaker Sanofi has just invested $59 million in biotech investor Jeito Capital to fund innovation in the biopharma pipeline

Sanofi, one of the world's biggest pharmaceutical companies, has invested €50 million in new French…

Theo Golden,Dr. Catherine Sch…   


Business Insider Latest Story Image
6 mins read

Pfizer's coronavirus vaccine relies on a new, unproven technology. A diagram shows how it differs from other candidates.

Pfizer announced Monday that its mRNA vaccine, which relies on a snippet of the virus' genome, succ…

Aria Bendix   


Business Insider Latest Story Image
1 min read

Sanofi, GSK start human trial of their Covid-19 vaccine

Paris, Sep 3 (IANS) Pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) on Thursday started a …

Business Insider Latest Story Image
3 mins read

Trump expects a COVID-19 vaccine to arrive this fall, according to a new report — an optimistic timeline that many doubt will come true

Vaccine manufacturers have been working with unusual speed, but many experts predict a much-longer …

Sinéad Baker   


Business Insider Latest Story Image
1 min read

Drugmakers Sanofi and GSK launch human trials for COVID-19 vaccine

The major European drug companies have begun testing their coronavirus vaccine on humans in the US …

Kate Duffy   


Business Insider Latest Story Image
2 mins read

Sanofi, GSK to support COVAX with 200mn doses of Covid-19 vaccine

London/Paris, Oct 28 (IANS) Drugmakers Sanofi and GlaxoSmithKline on Wednesday said they plan to ma…

Business Insider Latest Story Image
3 mins read

Sanofi walked back a promise to give the US priority access to its coronavirus vaccine after outrage from the French government

CEO Paul Hudson previously said the US "has the right" to its potential vaccine because it had cont…

Bill Bostock   


Business Insider Latest Story Image
2 mins read

The US would be the first to get a potential coronavirus vaccine being created by a French company, its CEO said

The CEO of Sanofi told Bloomberg the United States would be first because it was the earliest to fu…

Bryan Pietsch   


Business Insider Latest Story Image
8 mins read

Even if a successful coronavirus vaccine is developed, billions could struggle to access it because of a global shortage of glass vials

Vaccines are stored in glass vials, which are running low, slow to produce, and invariably the main…

Bill Bostock